1. Home
  2. AUPH vs TPB Comparison

AUPH vs TPB Comparison

Compare AUPH & TPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • TPB
  • Stock Information
  • Founded
  • AUPH 1993
  • TPB 1988
  • Country
  • AUPH Canada
  • TPB United States
  • Employees
  • AUPH N/A
  • TPB N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • TPB Tobacco
  • Sector
  • AUPH Health Care
  • TPB Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • TPB Nasdaq
  • Market Cap
  • AUPH 1.6B
  • TPB 1.6B
  • IPO Year
  • AUPH 1999
  • TPB 2016
  • Fundamental
  • Price
  • AUPH $16.44
  • TPB $100.27
  • Analyst Decision
  • AUPH Strong Buy
  • TPB Strong Buy
  • Analyst Count
  • AUPH 3
  • TPB 5
  • Target Price
  • AUPH $17.67
  • TPB $93.75
  • AVG Volume (30 Days)
  • AUPH 2.2M
  • TPB 428.9K
  • Earning Date
  • AUPH 11-04-2025
  • TPB 11-05-2025
  • Dividend Yield
  • AUPH N/A
  • TPB 0.30%
  • EPS Growth
  • AUPH N/A
  • TPB N/A
  • EPS
  • AUPH 0.55
  • TPB 0.20
  • Revenue
  • AUPH $265,808,000.00
  • TPB $435,716,000.00
  • Revenue This Year
  • AUPH $17.33
  • TPB $24.45
  • Revenue Next Year
  • AUPH $14.31
  • TPB $8.46
  • P/E Ratio
  • AUPH $29.89
  • TPB $509.43
  • Revenue Growth
  • AUPH 20.62
  • TPB 51.72
  • 52 Week Low
  • AUPH $6.55
  • TPB $51.48
  • 52 Week High
  • AUPH $16.47
  • TPB $110.55
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 75.78
  • TPB 57.12
  • Support Level
  • AUPH $14.94
  • TPB $95.75
  • Resistance Level
  • AUPH $15.81
  • TPB $103.01
  • Average True Range (ATR)
  • AUPH 0.61
  • TPB 3.49
  • MACD
  • AUPH 0.06
  • TPB -0.26
  • Stochastic Oscillator
  • AUPH 97.97
  • TPB 44.72

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About TPB Turning Point Brands Inc.

Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.

Share on Social Networks: